Is atomoxetine like adderall?

Not exactly. Atomoxetine (Strattera) and Adderall are both used to treat ADHD, but they work very differently and have different use patterns.

- Mechanism
- Atomoxetine: a selective norepinephrine reuptake inhibitor (NRI). It increases norepinephrine in the brain.
- Adderall: a stimulant that boosts dopamine and norepinephrine by promoting release and also blocking reuptake.

- When they’re used
- Both treat ADHD in children and adults, but stimulants like Adderall are often first-line due to stronger and faster symptom relief.
- Atomoxetine is a non-stimulant option, useful if someone doesn’t tolerate stimulants well, has certain anxiety/tic concerns, or has a risk of misuse/substance use.

- Onset of effect
- Adderall: effects can be felt within hours after dosing.
- Atomoxetine: improvement typically takes several weeks (often 2–4 weeks or more) to become noticeable.

- Efficacy
- Adderall: generally very effective for core ADHD symptoms, especially inattention and hyperactivity/impulsivity.
- Atomoxetine: effective for ADHD but may be somewhat less robust for some people; can be as helpful as a non-stimulant alternative when stimulants aren’t suitable.

- Side effects and safety
- Adderall: common issues include insomnia, decreased appetite/weight loss, increased blood pressure and heart rate, anxiety, and potential for misuse.
- Atomoxetine: common issues include stomach upset, decreased appetite, dizziness, fatigue, and sometimes mood changes; has a cautioned liver injury risk in rare cases and a small risk of suicidal thoughts in some children/adolescents; less potential for abuse.
- Both can raise blood pressure/heart rate modestly; monitor with a clinician.
- MAOI interactions: atomoxetine has interactions with MAO inhibitors; stimulants have their own interaction considerations.

- Abuse potential
- Adderall: higher potential for misuse/abuse (Schedule II in the U.S.).
- Atomoxetine: not a stimulant and has low abuse potential.

- Special considerations
- If there are coexisting conditions like anxiety, tics, or a history of substance use, a clinician may choose one option over the other based on your individual situation.
- Dosing and monitoring differ; regular follow-up with a healthcare provider is important for both.

If you want, tell me a bit about the specific situation (age, symptoms, any health issues, whether a stimulant was tried before and how it went). I can tailor the comparison to what might be most relevant for you.